YuanMing Capital
Asia, Beijing, China, Haidian'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
YuanMing Capital is a healthcare specialty fund focusing on China-US cross border investments.
Investor Profile
YuanMing Capital has backed more than 8 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Private Equity rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Series A (25%)
- Seed (25%)
- Private Equity (13%)
- Series D (13%)
- Series B (13%)
- Series F (13%)
Country Focus
- China (63%)
- United States (25%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Pharmaceutical
- Therapeutics
- Biopharma
- Manufacturing
- Oncology
- Clinical Trials
- Hospital
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
